Syros Pharmaceuticals, Inc. (SYRS) Files Form 4 Insider Buying : Amir Nashat Buys 400,000 Shares

Syros Pharmaceuticals, Inc. (SYRS): Amir Nashat , director 10% owner of Syros Pharmaceuticals, Inc. purchased 400,000 shares on Jul 6, 2016. The Insider buying transaction was reported by the company on Jul 7, 2016 to the Securities and Exchange Commission. The shares were purchased at $12.50 per share for a total value of $5,000,000.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Jul 6, 2016, Robert Nelsen (director 10% owner) purchased 400,000 shares at $12.50 per share price.

Leave a Reply

Syros Pharmaceuticals, Inc. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Syros Pharmaceuticals, Inc.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.